Ro-44-3888
Подписчиков: 0, рейтинг: 0
| Identifiers | |
|---|---|
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H24N4O5 |
| Molar mass | 376.413 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.
See also
| Antiplatelet drugs |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticoagulants |
|
||||||||||||||
|
Thrombolytic drugs/ fibrinolytics |
|||||||||||||||
| Non-medicinal | |||||||||||||||
| |||||||||||||||